MedTrace Logo

Tracking of Lipid Lowering Therapy in Jordan

NCT05629767 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-13

No results posted yet for this study

Summary

The present study aims to examine the clinical practice of modifying the dose of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease (ASCVD), who have LDL-C \> 70 mg/dl despite statin treatment.

Conditions

Sponsors & Collaborators

  • Jordan Collaborating Cardiology Group

    lead OTHER

Principal Investigators

  • Ayman Hammoudeh, MD FACC · Istishari Hospital, Amman, Jordan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-11
Primary Completion
2023-12-13
Completion
2024-01-02

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05629767 on ClinicalTrials.gov